CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Other disposition · Restricted Stock Unit | −2,038 | 10,728 | ||
| 2021-08-09 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Gift | −523 | 41,053 | ||
| 2021-07-01 | DENNER ALEXANDER J Director | Grant or award | +775 | 13,729 | ||
| 2021-07-01 | DORSA CAROLINE Director | Grant or award | +775 | 21,872 | ||
| 2021-07-01 | SHERWIN STEPHEN A Director | Grant or award | +775 | 17,103 | ||
| 2021-07-01 | Rowinsky Eric K Director | Grant or award | +775 | 17,844 | ||
| 2021-07-01 | Posner Brian S Director | Grant or award | +775 | 8,175 | ||
| 2021-07-01 | Mulligan Richard Director | Grant or award | +775 | 13,729 | ||
| 2021-07-01 | LEAMING NANCY Director | Grant or award | +775 | 13,763 | ||
| 2021-07-01 | Freire Maria C Director | Grant or award | +775 | 775 | ||
| 2021-07-01 | PAPADOPOULOS STELIOS Director | Grant or award | +1,275 | 7,840 | ||
| 2021-07-01 | HAWKINS WILLIAM A Director | Grant or award | +775 | 2,820 | ||
| 2021-07-01 | Mantas Jesus B Director | Grant or award | +775 | 3,718 | ||
| 2021-07-01 | JONES WILLIAM D /CA/ Director | Grant or award | +775 | 775 | ||
| 2021-07-01 | Kramer Robin Chief Accounting Officer | Option exercise | +251 | $348.92 | $88K | 945.35 |
| 2021-07-01 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −74 | $348.92 | $26K | 871.35 |
| 2021-07-01 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −251 | 504 | ||
| 2021-06-07 | Sandrock Alfred Head of Research & Development | Sale | −7,672 | $440.00 | $3.4M | 10,169.11 |
| 2021-06-07 | Guindo Chirfi Head of Glob Prod Strat & Com | Sale | −3,087 | $440.00 | $1.4M | 2,919 |
| 2021-06-04 | Posner Brian S Director | Sale | −360 | $274.17 | $99K | 7,400 |
Page 35 of 45 · 886 trades